Gemfibrozil and Lys drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gemfibrozil (gemfibrozil) and Lys (lysine). Common drug interactions include cardiac failure congestive among females and apathy among males.

The phase IV clinical study analyzes what interactions people have when they take Gemfibrozil and Lys. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Gemfibrozil?

Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 18,213 Gemfibrozil users. Check the latest studies of Gemfibrozil.

What is Lys?

Lys has active ingredients of lysine. eHealthMe is studying from 16,532 Lys users. Check the latest studies of Lys.

On Jul, 17, 2026

19 people who take Gemfibrozil and Lys together, and have interactions are studied.

What are the common drug interactions of Gemfibrozil and Lys, by gender? *:

female:

Cardiac failure congestive
Colitis ulcerative (inflammation of colon with ulcer)
Infusion site pain
Upper respiratory tract infection
Urinary tract infection
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood magnesium decreased
Blood potassium decreased
Nausea (feeling of having an urge to vomit)
Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)

male:

Apathy
Arterial rupture
Ulcer
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Fatigue (feeling of tiredness)
Full blood count decreased
Hemiplegia (paralysis of one side of the body)
Malaise (a feeling of general discomfort or uneasiness)
Memory impairment

What are the common drug interactions of Gemfibrozil and Lys, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal pain upper
Arthralgia (joint pain)
Drug ineffective
Fatigue (feeling of tiredness)
Hypertension (high blood pressure)
Hypogeusia (reduced ability to taste things (to taste sweet, sour, bitter, or salty substances))
Injection site discolouration
Injection site haematoma (localized swelling filled with blood at injection site)
Irritability
Nausea (feeling of having an urge to vomit)

50-59:

Arterial rupture
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Hemiplegia (paralysis of one side of the body)
Memory impairment
Tremor (trembling or shaking movements in one or more parts of your body)
Ulcer

60+:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood magnesium decreased
Blood pressure decreased
Chronic kidney disease
Dyspnoea (difficult or laboured respiration)
Neck pain
Respiratory tract infection
Syncope (loss of consciousness with an inability to maintain postural tone)
Agitation (state of anxiety or nervous excitement)
Apathy

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 6 people, 31.58%
Immunodeficiency Common Variable: 6 people, 31.58%
Muscle Spasms (muscle contraction): 5 people, 26.32%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 21.05%
High Blood Pressure: 4 people, 21.05%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 21.05%
Bone Disorder: 3 people, 15.79%
Diabetes: 3 people, 15.79%
Menopause (end of monthly cycles in women): 3 people, 15.79%
Oral Herpes (viral infection of mouth): 3 people, 15.79%

* Approximation only. Some reports may have incomplete information.

Do you take Gemfibrozil and Lys?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously